Transmission Dynamics of SARS-CoV-2 during an Outbreak in a Roma Community in Thessaly, Greece-Control Measures and Lessons Learned.

COVID-19 SARS-CoV-2 asymptomatic transmission control measures household transmission vulnerable populations

Journal

International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455

Informations de publication

Date de publication:
11 03 2021
Historique:
received: 18 01 2021
revised: 26 02 2021
accepted: 07 03 2021
entrez: 3 4 2021
pubmed: 4 4 2021
medline: 10 4 2021
Statut: epublish

Résumé

A COVID-19 outbreak occurred among residents of a Roma settlement in Greece (8 April-4 June 2020). The aim of this study was to identify factors associated with an increased risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and to evaluate the effectiveness of control measures implemented. Data were analyzed from individuals that were tested for SARS-CoV-2 during contact tracing, population screening or hospital visits. RT-PCR was used for the detection of SARS-CoV-2 in oropharyngeal samples. Risk factors for household secondary attack rates (SAR) and hospitalization with COVID-19 were examined using chi-square tests, Fisher's exact tests and logistic regression analyses. During the outbreak, 142 cases, 20 hospitalizations and 1 death were recorded, with a total of 2273 individuals tested. The risk of hospitalization was associated with age (OR: 1.04, 95% CI: 1.02-1.07) and Cycle threshold (Ct) values (OR for a decrease in Ct values by 1: 1.18, 95% CI: 1.07-1.31). Household SAR was estimated at 38.62% (95% CI: 32.50-45.01%). After the designation of an isolation facility for cases, household SAR declined from 74.42% to 31.03%. Household size was associated with the risk of infection (OR: 2.65, 95% CI: 1.00-7.07). The presence of COVID-19 symptoms among index cases was correlated with higher transmission (OR: 23.68, 95% CI 2.21-253.74) in multivariate analysis, while age was found to be associated with SAR only in univariate analysis. Roma communities can be particularly vulnerable to the spread of SARS-CoV-2. In similar settings, symptomatic cases are more important transmitters of SARS-CoV-2. Within these communities, immediate measures should be implemented to mitigate disease spread.

Identifiants

pubmed: 33799791
pii: ijerph18062878
doi: 10.3390/ijerph18062878
pmc: PMC8002111
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Respir Med. 2008 Sep;102(9):1321-8
pubmed: 18606531
Int J Public Health. 2013 Dec;58(6):885-911
pubmed: 24096986
JAMA. 2020 Jul 28;324(4):390-392
pubmed: 32556085
Wellcome Open Res. 2020 May 1;5:83
pubmed: 32656368
Environ Res. 2020 Sep;188:109819
pubmed: 32569870
Ann Intern Med. 2020 Dec 1;173(11):879-887
pubmed: 32790510
Euro Surveill. 2020 Aug;25(31):
pubmed: 32762796
Am J Public Health. 2008 Nov;98(11):2035-41
pubmed: 18799769
J Paediatr Child Health. 2020 Jun;56(6):978-979
pubmed: 32542872
Infect Dis Ther. 2020 Sep;9(3):573-586
pubmed: 32725536
Int J Public Health. 2010 Oct;55(5):435-41
pubmed: 20229189
Lancet Glob Health. 2020 Aug;8(8):e1003-e1017
pubmed: 32553130
Environ Int. 2020 Jun;139:105730
pubmed: 32294574
Pediatrics. 2020 Aug;146(2):
pubmed: 32457212
Emerg Infect Dis. 2020 Oct;26(10):2465-2468
pubmed: 32673193
JAMA Netw Open. 2020 Dec 1;3(12):e2031756
pubmed: 33315116

Auteurs

Michalis Koureas (M)

Laboratory of Hygiene and Epidemiology, Faculty of Medicine, University of Thessaly, 41222 Larissa, Greece.

Matthaios Speletas (M)

Department of Immunology and Histocompatibility, Faculty of Medicine, University of Thessaly, 41110 Larissa, Greece.

Zacharoula Bogogiannidou (Z)

Laboratory of Hygiene and Epidemiology, Faculty of Medicine, University of Thessaly, 41222 Larissa, Greece.

Dimitris Babalis (D)

General Hospital of Larissa, 41221 Larissa, Greece.

Vassilios Pinakas (V)

Region of Thessaly, Koumoundourou & Papanastasiou str, 41222 Larissa, Greece.

Ourania Pinaka (O)

Laboratory of Hygiene and Epidemiology, Faculty of Medicine, University of Thessaly, 41222 Larissa, Greece.

Apostolos Komnos (A)

General Hospital of Larissa, 41221 Larissa, Greece.

Stella Tsoutsa (S)

General Hospital of Larissa, 41221 Larissa, Greece.

Georgia Papadamou (G)

Emergency Department, University Hospital of Larissa, Mezourlo, 41110 Larissa, Greece.

Maria A Kyritsi (MA)

Laboratory of Hygiene and Epidemiology, Faculty of Medicine, University of Thessaly, 41222 Larissa, Greece.

Alexandros Vontas (A)

Laboratory of Hygiene and Epidemiology, Faculty of Medicine, University of Thessaly, 41222 Larissa, Greece.

Vasileios Nakoulas (V)

Laboratory of Hygiene and Epidemiology, Faculty of Medicine, University of Thessaly, 41222 Larissa, Greece.

Spyros Sapoynas (S)

Hellenic National Public Health Organization, 15123 Athens, Greece.

Nikolaos Kanellopoulos (N)

Region of Thessaly, Koumoundourou & Papanastasiou str, 41222 Larissa, Greece.

Dimitrios Kalompatsios (D)

Laboratory of Hygiene and Epidemiology, Faculty of Medicine, University of Thessaly, 41222 Larissa, Greece.

Vassiliki Papadouli (V)

Local Health Unit of Ampelokipi, 5th Regional Health Authority of Thessaly & Sterea, Ministry of Health, 41447 Larissa, Greece.

Katerina Dadouli (K)

Laboratory of Hygiene and Epidemiology, Faculty of Medicine, University of Thessaly, 41222 Larissa, Greece.

Soteris Soteriades (S)

Laboratory of Hygiene and Epidemiology, Faculty of Medicine, University of Thessaly, 41222 Larissa, Greece.

Paraskevi Mina (P)

Laboratory of Hygiene and Epidemiology, Faculty of Medicine, University of Thessaly, 41222 Larissa, Greece.

Varvara A Mouchtouri (VA)

Laboratory of Hygiene and Epidemiology, Faculty of Medicine, University of Thessaly, 41222 Larissa, Greece.

Lemonia Anagnostopoulos (L)

Laboratory of Hygiene and Epidemiology, Faculty of Medicine, University of Thessaly, 41222 Larissa, Greece.

Kostantinos E Stamoulis (KE)

Hellenic National Blood Transfusion Center, 13677 Athens, Greece.

Kostantinos Agorastos (K)

Region of Thessaly, Koumoundourou & Papanastasiou str, 41222 Larissa, Greece.

Efthimia A Petinaki (EA)

Department of Microbiology, Faculty of Medicine, University of Thessaly, 41110 Larissa, Greece.

Panagiotis Prezerakos (P)

Department of Nursing, University of the Peloponnese, 22100 Tripoli, Greece.

Sotirios Tsiodras (S)

Medical School, National and Kapodistrian University of Athens, 15772 Athens, Greece.

Christos Hadjichristodoulou (C)

Laboratory of Hygiene and Epidemiology, Faculty of Medicine, University of Thessaly, 41222 Larissa, Greece.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH